Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galera Therapeutics (GRTX)
OTHER OTC:GRTX
Holding GRTX?
Track your performance easily
GRTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.29
Previous CloseN/A
Volume48.38K
Average Volume (3M)351.55K
Market Cap
$2.61M
Enterprise ValueN/A
Total Cash (Recent Filing)$14.18M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Mar 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding54,392,170
10 Day Avg. Volume79,038
30 Day Avg. Volume351,548
Standard Deviation0.44
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Galera Therapeutics News
PremiumCompany Announcements
Galera Therapeutics Expands with Nova Pharmaceuticals Acquisition
PremiumCompany Announcements
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
Ownership Overview
34.44% Insiders
<0.01% Mutual Funds
5.41% Other Institutional Investors
60.14% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GRTX FAQ
What was Galera Therapeutics’s price range in the past 12 months?
Galera Therapeutics lowest stock price was $0.02 and its highest was $0.29 in the past 12 months.
What is Galera Therapeutics’s market cap?
Galera Therapeutics’s market cap is $2.61M.
When is Galera Therapeutics’s upcoming earnings report date?
Galera Therapeutics’s upcoming earnings report date is Mar 06, 2025 which is in 33 days.
How were Galera Therapeutics’s earnings last quarter?
Currently, no data Available
Is Galera Therapeutics overvalued?
According to Wall Street analysts Galera Therapeutics’s price is currently Overvalued.
Does Galera Therapeutics pay dividends?
Galera Therapeutics does not currently pay dividends.
What is Galera Therapeutics’s EPS estimate?
Galera Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Galera Therapeutics have?
Galera Therapeutics has 54,392,170 shares outstanding.
What happened to Galera Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Galera Therapeutics?
Currently, no hedge funds are holding shares in GRTX
---
Company Description
Galera Therapeutics
Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
---
Technical Analysis
---